ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,568 | +490.3% | 16,985 | +626.8% | 0.00% | – |
| Q2 2023 | $15,681 | -60.3% | 2,337 | -47.8% | 0.00% | – |
| Q1 2023 | $39,541 | -86.7% | 4,478 | -88.5% | 0.00% | -100.0% |
| Q4 2022 | $296,348 | +958.4% | 38,789 | +1031.5% | 0.00% | – |
| Q2 2022 | $28,000 | -88.0% | 3,428 | -79.6% | 0.00% | – |
| Q1 2022 | $233,000 | +606.1% | 16,768 | +1970.1% | 0.00% | – |
| Q2 2021 | $33,000 | -52.9% | 810 | -53.2% | 0.00% | – |
| Q1 2021 | $70,000 | +59.1% | 1,731 | +17.1% | 0.00% | – |
| Q4 2019 | $44,000 | – | 1,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |